Search





Search





Markets
/
Stocks
/
avir
/

Atea Pharmaceuticals Inc

AVIR

Add to Watchlist

4.810USD

+0.080+1.69%

Close 07-27 16:00（ET）Quotes delayed by 15 min

384.93MMarket Cap

LossP/E TTM

Atea Pharmaceuticals Inc

4.810

+0.080+1.69%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-27

Previous score

7.00

Change

The current institutional shareholding score of Atea Pharmaceuticals Inc is 7.00, ranking 80 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 70.93%, representing a quarter-over-quarter decrease of 6.88%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.46% of shares outstanding, with 0.17% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

9.68M

+66.23%

BML Capital Management LLC

7.49M

+0.21%

BlackRock Institutional Trust Company, N.A.

6.23M

+0.35%

JPM Partner LLC

5.87M

Tang Capital Management, LLC

4.81M

-0.24%

Radoff Family Foundation

3.38M

+8.86%

Bain Capital Life Sciences Investors, LLC

2.49M

Geode Capital Management, L.L.C.

1.84M

-3.09%

Two Sigma Investments, LP

1.81M

+42.42%